Teva agrees to pay $126 mln to US hospitals over opioids, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Teva Pharmaceutical Industries Ltd. has agreed to settle accusations that its marketing of opioid medications increased the operational costs of U.S. hospitals by up to $126 million over 18 years. The Israeli pharmaceutical company Teva also promised to provide $49 million worth of the overdose-reversing medicine naloxone as part of the proposed settlement, which was announced in Teva’s quarterly earnings report on Wednesday., Teva Pharmaceutical Industries Ltd. has agreed to settle accusations that its marketing of opioid medications increased the operational costs of U.S. hospitals by up to $126 million over 18 years. The Israeli pharmaceutical company Teva also promised to provide $49 million worth of the overdose-reversing medicine naloxone as part of the proposed settlement, which was announced in Teva’s quarterly earnings report on Wednesday., , Read More